 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. Centers for Disease Control and Prevention
Glaxo Plans Another Price Cut in AIDS Drugs to Poor CountriesJune 11, 2001 GlaxoSmithKline PLC will announce today another round of price reductions for AIDS drugs in poor countries. The list price for three AIDS drugs -- Ziagen, Trizivir and Agenerase -- will be reduced to cost in 63 of the world's poorest countries. But even at those discounts, Jean-Pierre Garnier, Glaxo's chief executive, admitted the prices will keep the drugs out of reach for most patients.
Adapted from:
Back to other CDC news for June 11, 2001 Wall Street Journal 06.11.01; Rachel Zimmerman This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
E-Mail
Printable Single-Page
Glossary
Share
